The aim of this study was to compare the diagnostic accuracy of the late phase of CEUS and the hepatobiliary phase of CE-MR with Gd-BOPTA in the characterization of focal liver lesions in terms of benignity and malignancy. A total of 147 solid focal liver lesions (38 focal nodular hyperplasias, 1 area of focal steatosis, 3 regenerative nodules, 8 adenomas, 11 cholangiocarcinomas, 36 hepatocellular carcinomas and 49 metastases) were retrospectively evaluated in a multicentre study, both with CEUS, using sulphur hexafluoride microbubbles (SonoVue, Bracco, Milan, Italy) and CE-MR, performed with Gd-BOPTA (Multihance, Bracco, Milan, Italy). All lesions thought to be malignant were cytohistologically proven, while all lesions thought to be benign were followed up. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values and accuracy were calculated for the late phase of CEUS and the hepatobiliary phase of CE-MRI, respectively, and in combination. Analysis of data revealed 42 benign and 105 malignant focal liver lesions. We postulated that all hypoechoic/hypointense lesions on the two phases were malignant. The diagnostic errors were 13/147 (8.8%) by CEUS and 12/147 (8.2%) by CE-MR. Sensitivity, specificity, PPV, NPV and accuracy of the late phase of CEUS were 90%, 93%, 97%, 80% and 91%, 93%, 97%, 81% and 92% for the hepatobiliary phase of CE-MRI, respectively. If we considered both techniques, the misdiagnosis diminished to 3/147 (2%) and sensitivity, specificity, PPV, NPV and accuracy were 98%, 98%, 99%, 95% and 98%. The combination of the late phase of CEUS and the hepatobiliary phase of CE-MR in the characterization of solid focal liver lesions in terms of benignity and malignancy is more accurate than the two techniques used separately.
Introduction
Solid focal liver lesions (FLL) frequently represent a diagnostic problem. 1 In recent years, several studies have evaluated the diagnostic accuracy of contrast-enhanced ultrasonography (CEUS) and contrast-enhanced magnetic resonance (CE-MR). [2] [3] [4] It has already been proven that the late phase of contrast medium examinations may improve the detection and characterization of focal liver lesions. [5] [6] [7] [8] [9] [10] [11] [12] Guidelines recommend the use of CEUS in the characterization of FLL detected and indeterminate with conventional ultrasonography (US). 9, 10 The late phase plays a pivotal role for the differential diagnosis of benignancy vs. malignancy.
MRI is a powerful imaging method for FLL detection and characterization, especially when using liver specific contrast media, as reported in the literature. 4, 7, 8, 13, 14 Microbubble contrast agents used for US differ from hepatocyte-specific contrast agents used in MR in their purely intravascular distribution, without any interstitial phase. This explains the substantial concordance with MR imaging on arterial phase imaging and the relative discordance of enhancement patterns in the delayed phases of imaging. [15] [16] [17] [18] Some articles report a diagnostic accuracy between 85% and 95% in the distinction of benignancy and malignancy for the late phase of CEUS, 5, 19 compared to the 80-85% diagnostic accuracy of dynamic imaging, with a significant increase in diagnostic confidence compared with baseline US. 15, 20 Furthermore, other studies show that the hepatobiliary phase of CE-MRI allows better detection and characterization of solid focal liver lesions, particularly of metastases, compared to pre-contrast and dynamic imaging, because of the markedly improved lesion-to-liver contrast in the absence of perfusion changes. 4, 16 The aim of this study was to retrospectively compare the diagnostic accuracy of CEUS and CE-MR, using a hepatospecific contrast agent, in the characterization of focal liver lesions in terms of benignancy and malignancy.
Materials and methods

Study population
To evaluate the capability of CEUS and CE-MRI in the characterization of malignant focal liver lesions, consecutive solid focal liver lesions undetermined at US imaging and studied with CEUS and CE-MR imaging were retrospectively evaluated. Research ethics board approval for chart review was obtained for this multicentre study. All patients signed an informed consent form before each examination. We evaluated only patients where both examinations had been performed in the same institution within two weeks. Patients with cystic lesions or lesions characterized by a dynamic pattern typical for angiomatous vascular structures were excluded. The final diagnosis of lesions identified as malignant at imaging was obtained by core-needle biopsy, while all lesions thought to be benign were followed up within 6-12 months.
Imaging techniques
For the contrast enhanced ultrasound (CEUS), a contrast agent containing sulphur hexafluoride in the form of microbubbles (SonoVue, Bracco, Milan, Italy) was used and injected intravenously via an antecubital vein (dose of 2.4 mL) using a 20-gauge cannula as a rapid bolus, followed by a 5 mL saline flush. Harmonic microbubble-specific imaging with low acoustic US pressure (2-4 MHz transducer; mechanical index < 0.2; frame rate 12-13 Hz) was performed using Sequoia (Acuson-Siemens, Erlangen, Germany) and Aplio (Toshiba, Otawara, Japan) US scanners. All CEUS examinations were recorded on VHS/videotape or magneto-optical disk systems. A standard dynamic study was performed. It went through the arterial phase (about 15-25 seconds after contrast injection), the portal/ venous phase (about 40-60 seconds after contrast injection) and the late phase (about 120 seconds after contrast injection). We considered only the last phase.
All MR examinations were performed on a 1.5-T Magnetom Symphony scanner (Siemens), with high-performance gradients and a phased array body coil. A standard liver protocol was performed, which included an unenhanced spoiled gradient echo T1-weighted sequence in and out of phase (repetition time 75 ms, echo time 2.4 ms, inversion time 4.8 ms and flip angle 70 ), a turbo spin-echo T2-weighted sequence (repetition time 1800 ms, echo time 84 ms and echo train length 15), a turbo inversion recovery T2-weighted sequence (repetition time 5000 ms, echo time 103 ms, inversion time 145 ms and echo train length 33), axial breath hold sequence and a half Fourier acquisition T2-weighted (repetition time 1000 ms, echo time 82 ms, echo train length 144) 'free-breathing' fat-saturated sequence. The protocol also included a dynamic study, performed after the administration of dimeglumine-gadobenate (Gd-BOPTA, Multihance, Bracco, Milan, Italy) with a threedimensional fat-saturated gradient-echo T1-weighted volume interpolated breath hold examination ('VIBE', repetition time 4.5 ms, echo time 1.7 ms, flip angle 10 ), which was repeated 1-2 hours after Gd-BOPTA administration. Similarly, for the MR imaging, we only considered the last (hepatobiliary) phase.
All biopsies were performed under US guidance using a 20-, 19-or 18-gauge Menghini-type needle, with either automatic (Biomol, Hospital Service, Rome, Italy) or manual aspiration (Surecut, Hospital Service, Rome, Italy).
Analysis
Based on the enhancement patterns following contrast and on histopathology, we postulated that all lesions that appeared hypoechoic/hypointense on the late phase of CEUS or hepatobiliary phase of MRI respectively were malignant. In patients with more than one lesion with the same features, i.e. metastases, only the largest lesion was evaluated. We classed the adenomas as malignant lesions, due to the necessity of their surgical removal because of the risk of hemorrhage or malignant degeneration. 21 Considering only the late phase of CEUS and the hepatobiliary phase of MRI, focal liver masses were classified as hypoechoic/hypointense, iso-echoic/iso-intense or hyperechoic/hyper-intense relative to the rest of the liver parenchyma.
Statistics
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were calculated for the late CEUS and hepatobiliary MRI phases respectively and in combination.
Results
The study population consisted of 147 patients (93 men and 54 women) with a mean age of 59.4 years (age range: 17-75 years). Each patient had one or more focal liver lesions. In cases with more than one focal lesion, we evaluated only the largest lesion; mean lesion diameter was 5.8 cm (range: 0.4-10 cm).
Liver lesions comprised 38 focal nodular hyperplasias (FNHs), 1 area of focal steatosis, 3 regenerative nodules, 8 adenomas (one with focal degeneration), 11 cholangiocarcinomas (CCCs), 36 hepatocellular carcinomas (HCCs -one of these well differentiated and one fibrolamellar variant) and 49 metastases.
Analysis of late phase of CEUS data revealed 98 hypoechoic, 46 isoechoic and 3 hyperechoic lesions, while on the MR hepatobiliary phase the intensity was lower than, equal to or greater than that of the adjacent liver parenchyma, respectively, in 99, 39 and 4 cases and five lesions presented central pooling with peripheral wash-out.
Thus, the complete radiological analysis of data showed that there were 42 benign lesions, 39/42 (93%) of which were hyper-echoic or iso-echoic on the late phase of CEUS. Three of the 42 (7%) masses were hypoechoic on late phase of CEUS and therefore thought to be malignant, but histology revealed these to be FNHs. Also on the hepatobiliary phase of MRI, 39/42 (93%) were hyper-intense/ iso-intense and 3/42 (7%) were hypointense and so misdiagnosed; 1/42 (2.3%) was a FNH, 1/42 (2.3%) an area of focal steatosis and 1/42 (2.3%) a regenerative nodule. Only 1/42 (2.3%) diagnosis was mistaken by both techniques and the core-biopsy revealed it was a FNH.
The histo-pathological analysis of data showed that there were 105 malignant masses, 95/105 (90%) of which were hypoechoic on the late phase of CEUS. Ten of the 105 lesions (10%) were hyper-echoic/iso-echoic and so erroneously thought to be benign; actually, three of them were adenomas ( Figure 1 ) and seven were HCCs, respectively. Based on the hepatobiliary phase of MR, 96/105 (91%) were hypointense and so correctly diagnosed as malignant. Four of the 105 lesions (4%) were hyper-intense/iso-intense and 5/105 (5%) showed central pooling with peripheral wash out and were wrongly defined as benign masses.
The first four lesions were HCCs, and in the second group there were three metastases ( Figure 2 ) and two CCCs. Only 2/105 (2%) HCCs were misdiagnosed by both CEUS and CE-MRI; one was isoechoic on the late phase and hyperintense at the hepatobiliary phase and the other one was isohypoechoic/intense at both phases (Table 1) .
Evaluating all 147 focal liver lesions, our study showed that diagnostic errors were made in 13/147 (8.8%) by means of CEUS (Figures 1 and 2 ) and 12/147 (8.2%) by means of CE-MR (Figure 2 ), respectively. Considering both techniques combined, the rate of misdiagnosis decreased to 3/ 147 (2%).
Thus, the sensitivity calculated as the ratio of true positive to the total number of malignant focal liver masses was 90% for CEUS and 91% for CE-MRI, while the specificity, defined as the ratio of true negative to the total number of benign lesions, was 93% for both techniques. The PPV, calculated as the ratio between true positive and the sum of true and false positives, was 97% for both 95/98 masses and 96/99 masses, respectively. The NPV, derived from the ratio between true negative and the sum of true and false negatives, was 80% for CEUS and 81% for CE-MR. So, the diagnostic accuracy, defined as the ratio between true positive plus true negative and the total number of the lesions, was 91% for CEUS and 92% for CE-MR. The sensitivity, specificity, PPV, NPV and accuracy of the association between CEUS and CE-MR were 98%, 98%, 99%, 95% and 98%, respectively ( Table 2 ).
Discussion
The detection and characterization of solid focal liver lesions frequently represent a diagnostic challenge. The results obtained by ultrasonography and magnetic 19 the only phase useful for hepatic lesion characterization with CEUS is the late/sinusoidal phase, because it allows evaluation of the entire liver parenchyma. CEUS contrast agent clearly demonstrates the washout phenomenon, whereas CT and MRI may show prolonged enhancement due to contrast leakage into the tumour interstitium. 24, 25 MRI is used mainly in indeterminate cases, such as when US and/or CT are not fully definitive in terms of the number and location of liver lesions or when the differential diagnosis of selected liver lesions may affect subsequent patient treatment. 16 Different contrast materials, with different biological properties, are used in different clinical settings in MR liver imaging. Contrast materials with an interstitial distribution phase are not well suited for liver lesion detection because they alter both the normal liver parenchyma and the lesion equally. With these agents, the lesion-to-liver contrast is high only in the non-equilibrium perfusion phases, so that only the fast dynamic component is of any benefit. 16 Another possible way of MRI contrast distribution is the hepatobiliary pathway. Gadobenate dimeglumine (Gd-BOPTA, Multihance, Bracco) is a gadolinium chelate that combines the properties of a conventional extracellular fluid gadolinium agent with those of an agent targeted specifically to the liver. 18, 26, 27 The contrast-effective chelate of gadobenate dimeglumine is Gd-BOPTA, which has the capacity for weak and transient interaction with serum albumin, 28, 29 which markedly increases the r1 and r2 relaxivities of gadobenate dimelgumine relative to conventional gadolinium agents, permitting similar contrast enhancement to be obtained with lower doses. 30 Furthermore, around 96% of the injected dose of gadobenate dimeglumine is excreted renally via glomerular filtration, while the remaining 3-5% is taken up by functioning epatocytes and eliminated via the hepatobiliary pathway. 18, 26, 27 This property allows a marked and long-lasting increase in signal intensity of normal liver parenchyma, beginning around 40 minutes after contrast medium administration. 8, 16, 18, 26, 27, 31, 32 As a contrast agent for liver imaging, gadobenate dimeglumine therefore behaves analogously to conventional extracellular gadolinium agents during the initial dynamic phase of contrast enhancement and as a liver-specific agent during the delayed hepatobiliary phase. Thus, the conventional approach to lesion detection and characterization based on the differential distribution of contrast agent during the initial dynamic phase can be augmented by an additional functional approach in which lesion detection and characterization is based on the ability of lesions to take up and excrete Gd-BOPTA. 4, 13, 27, [33] [34] [35] [36] [37] Studies have shown that delayed hepatobiliary phase imaging can improve not only the detection of focal liver lesions but also the characterization of detected lesions, particularly lesions that demonstrate atypical enhancement patterns on dynamic imaging. 4, 13, 27, [33] [34] [35] [36] [37] In the light of these considerations, lesions with liver-like structures (sinusoidal network and hepatocytes), classified as benign, are usually iso-echoic/hyper-echoic in the late CEUS and iso-intense/hyper-intense in the hepatobiliary phase. 4, 38 Distribution and retention of the contrast microbubbles in the sinusoidal network without passage into the interstitium make the CEUS sinusoidal phase fundamental in distinguishing benign from malignant lesions (diagnosis of malignancy based on the presence of a clear hypoechoic defect in the sinusoidal phase was possible in about 96% of malignant focal liver lesions in a reported series). 19 During the late phase, lesions with liver-like (FNH, adenoma) or angiomatous (hemangiomas) vascular structure appear isoechoic or hyperechoic because of the retention of microbubbles similar to or greater than that in adjacent liver parenchyma. 17, 19, [39] [40] [41] [42] [43] [44] [45] [46] [47] Conversely, in those lesions with neoangiogenic vascular structure (HCC, CCC and metastases), there is not a similar degree of retention of microbubbles compared to the liver parenchyma. Therefore, malignant liver lesions typically appear as a clear hypoechoic defect inside the liver parenchyma, which is homogeneously enhanced during the late/ sinusoidal CEUS phase. 3, 17, 19, 39, 48 The sinusoidal phase of CEUS presents some limitations when evaluating the cirrhotic liver. Firstly, a minority of HCCs tend to maintain the original sinusoidal architecture, particularly in well-differentiated forms. 49 These vessels, which have an endothelial layer, are similar to those of normal liver and thus tend to accumulate microbubbles in the late phase of CEUS and do not show the typical washout of malignant lesions, as reported in literature. 50 Also, the focus of HCC is not always detectable as a clear defect due to fibrosis of adjacent parenchyma associated with a sinusoidal capillarization and with a loss of endothelial fenestrations and development of baseline membranes. 51 This may prevent the accumulation of microbubbles in the cirrhotic liver with a consequent decrease in hyperechogenicity and decreased conspicuity of lesions in the sinusoidal phase. 23 Thus, in our study 39/42 (93%) benign lesions were correctly detected and characterized both by the late phase of CEUS (35 FNHs, one area of focal steatosis and three regenerative nodules) and the hepatobiliary phase of CE-MR (37 FNHs and two regenerative nodules). A small number of benign lesions appeared hypoechoic/hypointense on the delayed phases, as reported in other series. 19, 52 In our series, three FNHs were erroneously diagnosed (falsely positive) by late CEUS. The immunohistopathological analysis demonstrated the presence of few anomalous sinusoidal vessels with a large number of vascular structures without cytologic atypia, for example in the non-classic FNH type. One of these atypical FNHs was misdiagnosed also by CE-MR. The focal area of steatosis was hypointense in the hepatobiliary phase, so resembling malignancy, because the sequence performed was a 'VIBE', a fat-saturated gradient-echo T1-weighted sequence, while in the late contrast-enhanced ultrasound it was hyperechoic, according to the normal echogenicity of fat. The further case that proved to be a false positive at the hepatobiliary phase of MRI was a large regenerative nodule (4 cm in diameter) that appeared normally hyperechoic on the delayed phase of CEUS. At CE-MRI, it showed a peripheral hypointensity because of functional failure of the hepatocytes due to the atrophic and congested perilesional area. Lesions with altered or absent sinusoids and/or hepatocytes, thus considered malignant, are usually hypoechoic/ hypointense in the late phases of CEUS and CE-MRI. 19, 52 In our study, 95/105 (90%) malignant masses were correctly detected and characterized by the late phase of CEUS (5 adenomas, 11 CCCs, 29 HCCs and 49 metastatic lesions from pancreatic, gastric and colo-rectal cancers) and 96/ 105 (91%) by the hepatobiliary phase of CE-MR (8 adenomas, 9 CCCs, 32 HCCs and 46 metastases from pancreatic, gastric and colo-rectal cancers).
Not all malignant focal liver masses appear hypoechoic/ intense in the delayed phases. 38, 53 In our series, three adenomas were misdiagnosed (false negative cases) because they were iso-hyperechoic in the late phase. Histo-pathological analysis of these cases revealed dilated vessels, large amounts of fat and the arterio-venous shunts. These mistakes were mostly made on hepatocellular carcinomas, which arise in cirrhotic liver, characterized by architectural parenchymal distortion, with fibrosis and late 'capillarization', with loss of endothelial fenestrations and development of baseline membranes. 54 Thus, seven out of 36 HCCs were erroneously interpreted as benign lesions (false negatives) by the late phase of CEUS because they were isoechoic. Immunohistochemical studies also reported that well-differentiated forms usually maintain the original parenchymal architecture. 13, 55 For the same reasons, four HCCs appeared iso-hyperintense in the hepatobiliary phase of MRI. This reflects the preservation of sufficient hepatocytic activity. 56 The other misdiagnoses observed at the delayed phase of CE-MRI were 2/9 CCCs and 3/46 metastases (all from colo-rectal cancer), which showed central pooling with peripheral wash out, due to the retention of the contrast in the central fibrous tissue. 52, 57 In contrast, these lesions were hypoechoic in the late phase of CEUS and so correctly diagnosed by this technique.
In our study, we demonstrated that considering the late phase of CEUS and the hepatobiliary phase of CE-MRI independently, the probability of a diagnostic error in terms of benignancy and malignancy is about 7% (3/42) for the truly benign focal liver lesions, and 10% (10/105) and 9% (9/105), respectively, for the truly malignant focal liver masses. However, if we considered both techniques together, the rate of misdiagnosis decreased to 2.3% (1/42) and to 2% (2/105) for benign and malignant lesions respectively, with the three misdiagnosed cases represented by an atypical FNH and two well-differentiated HCCs.
Conclusion
Imaging diagnosis of malignant focal liver lesions is accurate. In our study, diagnostic accuracy for the late phase of CEUS is about 91% and about 92% for the hepatobiliary late phase of CE-MR. Diagnostic accuracy was improved to around 98% by combining the two imaging methods. Ethical approval: Local Ethical Committee approval was obtained for the project. Contributorship: All authors contributed equally to this paper.
Abbreviations
